Study of the Effects of Tribulus Terrestris on Sexuality in Postmenopausal Women
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Objective: To study the effects of Tribulus terrestris on sexuality in postmenopausal women.
| Condition | Intervention |
|---|---|
|
Sexual Functions and Problems in the Adult |
Drug: Placebo Drug: Tribulus terrestris |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Double Blind (Caregiver, Investigator) Primary Purpose: Treatment |
| Official Title: | Study of the Effects of Tribulus Terrestris on Sexuality in Postmenopausal Women |
- Sexual Satisfaction Inventory- Female Version [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Effects of Tribulus terrestris on sexuality [ Time Frame: 3 months ] [ Designated as safety issue: No ]
| Enrollment: | 60 |
| Study Start Date: | January 2009 |
| Study Completion Date: | May 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Placebo Comparator: Placebo
1 tablet of placebo/ oral/ 3 times a day for three months
|
Drug: Placebo
1 tablet/ oral/ 3 times a day for 90 days
Other Name: lot 168159
|
|
Active Comparator: Tribulus terrestris
1 tablet of 250mg/ oral/ 3 times a day for three months
|
Drug: Tribulus terrestris
1 tablet of 250mg/ oral/ 3 times a day for 90 days
Other Name: lot 168059
|
Detailed Description:
Sexuality is an integral part of every personality, influence thoughts, feelings, actions, integrations, and therefore the physical and mental health. It is estimated that 43% of women have at least one complaint of sexual problem. Disorders of desire and arousal are among the most common problems found in gynecologic practice. Medicinal plants have been used for therapeutic purposes for thousands of years, and aphrodisiac properties described in several plants. Tribulus terrestris is a plant indigenous to India, recommended in the treatment of infertility, low libido and impotence, and its main active ingredient protodioscin (PTN).
Eligibility| Ages Eligible for Study: | 40 Years to 70 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Women past menopause, with full autonomy, at least one year of amenorrhea and FSH> 30 mIU / mL.
- Sexually active
- Partner is stable and without sexual difficulties
- Carrier sexual abuse (desire, arousal, orgasm and dyspareunia)
Exclusion Criteria:
- Women on hormone therapy
- Women without sexual activity
- With diabetes mellitus
- Patients with cognitive impairment
- Patients with hormone-dependent tumor
- History of current psychiatric illness and / or in the past
- Patients with liver disease, except for prior cholecystectomy.
- Patients with kidney disease
- Users of drugs with proven decrease in sexual desire.
Contacts and Locations| Brazil | |
| Santa Casa of Sao Paulo Medical School | |
| Sao Paulo, Brazil | |
| Principal Investigator: | Sonia lima, PhD | Faculdade de Ciências Médicas da Santa Casa de São Paulo |
More Information
No publications provided
| Responsible Party: | Sostenes Postigo, Fcmscsp |
| ClinicalTrials.gov Identifier: | NCT01407445 History of Changes |
| Other Study ID Numbers: | Fcmscsp-tribulus, terrestris |
| Study First Received: | August 1, 2011 |
| Last Updated: | August 1, 2011 |
| Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Faculdade de Ciências Médicas da Santa Casa de São Paulo:
|
Menopause Sexual dysfunction Tribulus Sexuality |
ClinicalTrials.gov processed this record on June 17, 2013